Biopharmaceutical Logistics

Global Biopharmaceutical Logistics Market to Reach US$143.9 Billion by 2030

The global market for Biopharmaceutical Logistics estimated at US$108.6 Billion in the year 2024, is expected to reach US$143.9 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the analysis period. Growth in the Non-cold Chain Logistics segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.8 Billion While China is Forecast to Grow at 4.3% CAGR

The Biopharmaceutical Logistics market in the U.S. is estimated at US$29.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$22.3 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

strong>Global Biopharmaceutical Logistics Market - Key Trends & Drivers Summarized

Why Is Biopharmaceutical Logistics Critical to the Healthcare Supply Chain?

Biopharmaceutical logistics is a specialized sector that ensures the safe and efficient transportation, storage, and distribution of temperature-sensitive pharmaceutical products, including vaccines, biologics, and other complex drugs. With the growing demand for biologics and the rise of personalized medicine, biopharmaceutical logistics has become more crucial than ever. Maintaining the integrity of these products through cold chain management, compliance with strict regulatory standards, and ensuring timely delivery are vital to safeguarding product efficacy. Failures in logistics can lead to costly wastage or loss of efficacy, making reliable logistics systems integral to the pharmaceutical supply chain.

How Are Technological Innovations Reshaping Biopharmaceutical Logistics?

Technological advancements are revolutionizing the biopharmaceutical logistics landscape, particularly in the area of cold chain management. IoT-enabled sensors, GPS tracking, and blockchain technologies are allowing real-time monitoring of shipments, ensuring that temperature, humidity, and other critical parameters are maintained throughout the logistics process. Automated storage systems, drone deliveries, and robotics are also improving the efficiency of handling and distribution in warehouses and transportation hubs. Additionally, blockchain is gaining traction for improving transparency and traceability, particularly for highly regulated biopharmaceutical products that require a clear audit trail from manufacturing to patient delivery.

Which Global Trends Are Impacting the Demand for Biopharmaceutical Logistics?

Several global trends are influencing the growth of the biopharmaceutical logistics market. The COVID-19 pandemic significantly increased the demand for robust cold chain logistics due to the global distribution of temperature-sensitive vaccines. Furthermore, the rise in biologics, which require specific storage and transportation conditions, has underscored the importance of specialized logistics providers. Globalization of the biopharmaceutical industry has also heightened the need for efficient logistics solutions that can handle long-distance and cross-border shipments while complying with diverse regulatory standards. Finally, the rise of e-commerce and direct-to-consumer delivery models has introduced new complexities in ensuring the last-mile delivery of pharmaceutical products.

The growth in the biopharmaceutical logistics market is driven by several factors, including the increasing demand for biologics and vaccines, the expansion of cold chain logistics infrastructure, and advancements in tracking and monitoring technologies. The shift towards personalized medicine and patient-specific biologics is also boosting the need for specialized logistics services. Moreover, the growing complexity of regulatory requirements and the need for compliance with Good Distribution Practices (GDP) are further fueling the demand for reliable and transparent logistics solutions. As pharmaceutical companies expand globally, the demand for scalable, efficient, and secure logistics services continues to rise, driving growth in this market.

SCOPE OF STUDY:

The report analyzes the Biopharmaceutical Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Service (Transportation, Warehousing); Type (Cold Chain Logistics, Non-cold Chain Logistics)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Agility
• AmerisourceBergen Corporation
• DB Schenker
• DHL International GmbH
• FedEx
• GEODIS
• Kerry Logistics Network Limited
• Kuehne + Nagel
• Nippon Express
• Panalpina
• SF Express
• Sinotrans
• United Parcel Service of America, Inc.
• VersaCold
• XPO Logistics

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more